LIMD1
Basic information
Region (hg38): 3:45555394-45686341
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIMD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 5 | 1 |
Variants in LIMD1
This is a list of pathogenic ClinVar variants found in the LIMD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-45594902-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
3-45594937-A-G | not specified | Uncertain significance (Feb 14, 2023) | ||
3-45594939-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
3-45594976-A-C | not specified | Uncertain significance (Aug 04, 2023) | ||
3-45595145-G-A | not specified | Likely benign (Dec 15, 2023) | ||
3-45595162-A-T | not specified | Uncertain significance (Aug 04, 2023) | ||
3-45595196-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
3-45595219-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
3-45595222-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
3-45595256-C-T | not specified | Likely benign (Jan 23, 2024) | ||
3-45595337-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
3-45595403-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
3-45595450-G-A | not specified | Uncertain significance (Mar 31, 2023) | ||
3-45595469-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
3-45595498-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
3-45595514-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
3-45595514-C-T | not specified | Likely benign (Mar 29, 2022) | ||
3-45595546-G-A | not specified | Likely benign (Aug 02, 2021) | ||
3-45595615-G-A | not specified | Uncertain significance (Nov 07, 2022) | ||
3-45595622-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
3-45595637-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
3-45595688-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
3-45595783-G-A | not specified | Uncertain significance (May 16, 2023) | ||
3-45595906-T-A | not specified | Uncertain significance (Jul 13, 2021) | ||
3-45595937-C-T | not specified | Uncertain significance (Dec 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LIMD1 | protein_coding | protein_coding | ENST00000273317 | 8 | 130945 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.417 | 0.583 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.477 | 368 | 395 | 0.932 | 0.0000214 | 4372 |
Missense in Polyphen | 85 | 106.95 | 0.79478 | 1225 | ||
Synonymous | -0.407 | 173 | 166 | 1.04 | 0.00000981 | 1419 |
Loss of Function | 3.76 | 6 | 27.1 | 0.221 | 0.00000149 | 295 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000209 | 0.000209 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000971 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing and is essential for P-body formation and integrity. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Acts as a transcriptional corepressor for SNAI1- and SNAI2/SLUG- dependent repression of E-cadherin transcription. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. Inhibits E2F-mediated transcription, and suppresses the expression of the majority of genes with E2F1- responsive elements. Regulates osteoblast development, function, differentiation and stress osteoclastogenesis. Enhances the ability of TRAF6 to activate adapter protein complex 1 (AP-1) and negatively regulates the canonical Wnt receptor signaling pathway in osteoblasts. May act as a tumor suppressor by inhibiting cell proliferation. {ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22286099}.;
- Pathway
- Hippo signaling pathway - Homo sapiens (human);Hippo signaling pathway - multiple species - Homo sapiens (human);Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Regulation of Hypoxia-inducible Factor (HIF) by oxygen;Cellular response to hypoxia;Cellular responses to stress;Cellular responses to external stimuli;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.0959
Intolerance Scores
- loftool
- 0.327
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.98
Haploinsufficiency Scores
- pHI
- 0.395
- hipred
- N
- hipred_score
- 0.414
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.463
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Limd1
- Phenotype
- immune system phenotype; hematopoietic system phenotype; skeleton phenotype;
Gene ontology
- Biological process
- response to hypoxia;osteoblast development;regulation of transcription, DNA-templated;cytoskeleton organization;signal transduction;multicellular organism development;regulation of cell shape;phosphorylation;cell migration;cytoplasmic mRNA processing body assembly;gene silencing by miRNA;negative regulation of hippo signaling;negative regulation of osteoblast differentiation;negative regulation of transcription, DNA-templated;regulation of transcription from RNA polymerase II promoter in response to hypoxia;negative regulation of canonical Wnt signaling pathway;positive regulation of gene silencing by miRNA
- Cellular component
- P-body;nucleus;transcription factor complex;cytoplasm;cytosol;plasma membrane;cell-cell junction;adherens junction;focal adhesion;RISC complex
- Molecular function
- transcription corepressor activity;protein binding;zinc ion binding